This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ferrara JL, Levine JE, Reddy P, Holler E . Graft-versus-host-disease. Lancet 2009; 373: 1550–1561.
Enk CD, Elad S, Vexler A, Kapelushnik J, Gorodetsky R, Kirschbaum M . Chronic graft-versus-host-disease treated with UVB phototherapy. Bone Marrow Transplant 1998; 22: 1179–1183.
Brazzelli V, Grasso V, Muzio F, Moggio E, Zecca M, Locatelli F et al. Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft versus host disease in oncohaematological paediatric patients. Br J Dermatol 2010; 162: 404–409.
Furlong T, Leisenring W, Storb R, Anasetti C, Appelbaum FR, Carpenter PA et al. Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft versus host disease. Biol Blood Marrow Transplant 2002; 8: 206–212.
Vogelsang GB, Wolff D, Altomonte VA, Farmer E, Morison WL, Corio R et al. Treatment of chronic graft versus host disease with ultraviolet irradiation and Psoralen (PUVA). Bone Marrow Transplant 1996; 17: 1061–1067.
Wiesmann A, Weller A, Lischka G, Klingebiel T, Kanz L, Einsele H . Treatment of acute graft versus host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study. Bone Marrow Transplant 1999; 23: 151–155.
Feldstein JV, Bolanos-Maede J, Anders VL, Abnav R . Narrowband ultraviolet B phototherapy for the treatment of steroid refractory and steroid dependent acute graft versus –host disease of the skin. J Am Acad Dermatol 2011; 65: 733–738.
Grundmann-Kollmann M, Martin H, Ludwig R, Klein S, Boehncke WH, Hoelzer D et al. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. Transplantation 2002; 74: 1631–1634.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 consensus conference on AGvHD grading. Bone Marrow Transplant 1995; 15: 825–828.
Schlaak M, Schwind S, Wetzig T, Maschke J, Treudler R, Basara N et al. UVA (UVA- 1) therapy for the treatment of acute GvHD of the skin. Bone Marrow Transplant 2010; 45: 1741–1748.
Iyama S, Murase K, Sato T, Hashimoto A, Tatekoshi A, Horiguchi H et al. Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells. Int J Hematol 2014; 99: 471–476.
Kreutz M, Karrer S, Hoffmann P, Gottfried E, Szeimies RM, Hahn J et al. Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute Graft-versus-host disease. J Invest Dermatol 2012; 132: 179–187.
Jampel RM, Farmer ER, Vogelsang GB, Wingard J, Santos GW, Morison WL . PUVA therapy for chronic cutaneous graft-vs-host disease. Arch Dermatol 1991; 127: 1673–1678.
Aubin F, Brion A, Deconinck E, Plouvier E, Hervé P, Humbert P et al. Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients. Transplantation 1995; 59: 151–155.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
George, L., Peter, D., Chopra, M. et al. Efficacy of narrow band UVB in the treatment of cutaneous GvHD: an Indian experience. Bone Marrow Transplant 51, 988–990 (2016). https://doi.org/10.1038/bmt.2016.13
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.13
This article is cited by
-
Understanding and treatment of cutaneous graft-versus-host-disease
Bone Marrow Transplantation (2023)